63 results
6-K
TAK
Takeda Pharmaceutical Co
24 Jun 20
Current report (foreign)
3:31pm
classified as Level 1, 2 or 3 within the fair value hierarchy as described in the accounting standards for fair value measurements:
Level 1 - Fair … to the fair value measurement and unobservable.
The majority of the Company’s financial assets have been classified as Level 1 and 2. The Company’s
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 May 23
Current report (foreign)
6:14am
are classified, at initial recognition, as financial liabilities measured at FVTPL, bonds and loans, or payables. Financial liabilities, except for those measured … and other plans such as post- retirement medical care as post- employment benefit plans. They are classified into defined benefit plans and defined
6-K
TAK
Takeda Pharmaceutical Co
29 May 20
Current report (foreign)
6:20am
, privacy and preserves the integrity of research.
Assets and liabilities related to SHP647, which were previously classified as held for sale … on Takeda’s consolidated statements of financial position, have ceased to be classified as held for sale as the result of the EC’s decision. Takeda will reverse
6-K
TAK
Takeda Pharmaceutical Co
10 Nov 20
Current report (foreign)
6:01am
and intangible assets related to the product were classified as the disposal groups held for sale as of September 30, 2020.
In May 2020, the European … Commission released Takeda from the obligation to divest SHP647, which Takeda classified as the disposal groups held for sale as of March 31, 2020
20FR12B
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
effective interest rate, with consideration of the credit risk by each liability group classified in a specified period.
Other current items … within a year are included. The fair value of bonds, long-term loans and finance leases are classified as Level 2 in the fair value hierarchy
6-K
2ircp8rz
9 Aug 19
Current report (foreign)
6:06am
20FR12B/A
EX-99.1
k1n0dq1a92b3rsua34ht
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
DRS/A
EX-99.1
3ufbfo3lei
16 Nov 18
Draft registration statement (amended)
12:00am
6-K
kjaxl5 xn
12 Feb 21
Current report (foreign)
6:04am
6-K
6e26ge sr
12 Aug 20
Current report (foreign)
6:10am
6-K
aer6lyx9cnswo4hpz8t
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
dukhy jq5i
27 Jul 23
Current report (foreign)
6:05am
6-K
jfjs2 werfxai
13 Feb 20
Current report (foreign)
6:05am
6-K
ee5c1t29
12 Nov 19
Current report (foreign)
6:04am
6-K
EX-99.1
0xy484jfbslfr
30 Oct 23
Current report (foreign)
6:02am
6-K
EX-99.1
rvjyn7psc7f
1 Feb 24
Current report (foreign)
6:06am
6-K
EX-99.1
efc3lswv w3z
26 Oct 23
Current report (foreign)
6:20am
6-K
hm2b72
27 May 20
Current report (foreign)
6:05am
6-K
kuargu8
30 Oct 23
Current report (foreign)
6:02am
6-K
0dd9rl691gb jhhx
22 Jun 20
Current report (foreign)
6:13am